Nemanja Djoković

448 total citations
17 papers, 294 citations indexed

About

Nemanja Djoković is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Nemanja Djoković has authored 17 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Nemanja Djoković's work include Histone Deacetylase Inhibitors Research (6 papers), Computational Drug Discovery Methods (5 papers) and Protein Degradation and Inhibitors (5 papers). Nemanja Djoković is often cited by papers focused on Histone Deacetylase Inhibitors Research (6 papers), Computational Drug Discovery Methods (5 papers) and Protein Degradation and Inhibitors (5 papers). Nemanja Djoković collaborates with scholars based in Serbia, Germany and United States. Nemanja Djoković's co-authors include Katarina Nikolić, Dušan Ružić, Teodora Djikić, Tatjana Srdić‐Rajić, Juan F. Santibáñez, César Echeverría, Olalla Vázquez, Jing Xu, Lea Albert and Lars‐Oliver Essen and has published in prestigious journals such as Journal of the American Chemical Society, Molecules and Journal of Chemical Information and Modeling.

In The Last Decade

Nemanja Djoković

16 papers receiving 287 citations

Peers

Nemanja Djoković

CTM

ONCOL

Dušan Ružić Serbia

Jörn Weisner Germany

David Critton United States

Adriana Stroba Germany

Mangalika Warthaka United States

Ganesh babu Manoharan Luxembourg

Zhang‐Bao Xu United States

Betsy S. Pierce United States

Jesús Vázquez Spain

Tadashi Terasaka Japan

Dušan Ružić Serbia

Nemanja Djoković

235 ×1.2

114 ×1.3

85 ×1.3

CTM

56 ×1.0

56 ×1.4

ONCOL

Citations per year, relative to Nemanja Djoković Nemanja Djoković (= 1×) peers Dušan Ružić

Countries citing papers authored by Nemanja Djoković

Since Specialization

Citations

This map shows the geographic impact of Nemanja Djoković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nemanja Djoković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nemanja Djoković more than expected).

Fields of papers citing papers by Nemanja Djoković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nemanja Djoković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nemanja Djoković. The network helps show where Nemanja Djoković may publish in the future.

Co-authorship network of co-authors of Nemanja Djoković

This figure shows the co-authorship network connecting the top 25 collaborators of Nemanja Djoković. A scholar is included among the top collaborators of Nemanja Djoković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nemanja Djoković. Nemanja Djoković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Djoković, Nemanja, et al.. (2024). Integration of 3D-QSAR, molecular docking, and machine learning techniques for rational design of nicotinamide-based SIRT2 inhibitors. Computational Biology and Chemistry. 113. 108242–108242.

Djoković, Nemanja, Ana Djurić, Dušan Ružić, Tatjana Srdić‐Rajić, & Katarina Nikolić. (2023). Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma. Pharmaceuticals. 16(2). 294–294. 4 indexed citations

Djoković, Nemanja, et al.. (2023). Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. Pharmaceutics. 15(11). 2581–2581. 15 indexed citations

Djoković, Nemanja, Minna Rahnasto‐Rilla, Nikolaos Lougiakis, Maija Lahtela‐Kakkonen, & Katarina Nikolić. (2023). SIRT2i_Predictor: A Machine Learning-Based Tool to Facilitate the Discovery of Novel SIRT2 Inhibitors. Pharmaceuticals. 16(1). 127–127. 4 indexed citations

Zhang, Lei, Xiulan Xie, Nemanja Djoković, et al.. (2023). Reversible Control of RNA Splicing by Photoswitchable Small Molecules. Journal of the American Chemical Society. 145(23). 12783–12792. 7 indexed citations

Bon, Corentin, Nemanja Djoković, Dušan Ružić, et al.. (2022). Quinazoline-Based Analog of Adenine As an Antidote Against MLL-rearranged Leukemia Cells: Synthesis, Inhibition Assays and Docking Studies. Future Medicinal Chemistry. 14(8). 557–570. 1 indexed citations

Ružić, Dušan, Nemanja Djoković, Tatjana Srdić‐Rajić, et al.. (2022). Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics. 14(1). 209–209. 44 indexed citations

Djoković, Nemanja, Dušan Ružić, Minna Rahnasto‐Rilla, et al.. (2022). Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics. Journal of Chemical Information and Modeling. 62(10). 2571–2585. 10 indexed citations

Ružić, Dušan, Bernhard Ellinger, Nemanja Djoković, et al.. (2022). Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation. Pharmaceutics. 14(12). 2600–2600. 13 indexed citations

10.

Bon, Corentin, Yang Si, Corinne Jallet, et al.. (2021). Synthesis and Biological Activity of a Cytostatic Inhibitor of MLLr Leukemia Targeting the DOT1L Protein. Molecules. 26(17). 5300–5300. 11 indexed citations

11.

Djoković, Nemanja, Dušan Ružić, Teodora Djikić, et al.. (2021). An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease. Molecular Informatics. 40(5). e2000187–e2000187. 7 indexed citations

12.

Ružić, Dušan, Nemanja Djoković, & Katarina Nikolić. (2021). Fragment-Based Drug Design of Selective HDAC6 Inhibitors. Methods in molecular biology. 2266. 155–170. 9 indexed citations

13.

Albert, Lea, Jatin Nagpal, Wieland Steinchen, et al.. (2021). Bistable Photoswitch Allows in Vivo Control of Hematopoiesis. ACS Central Science. 8(1). 57–66. 21 indexed citations

14.

Djoković, Nemanja, et al.. (2021). Synthesis, in silico, and in vitro studies of novel dopamine D₂ and D₃ receptor ligands. Archiv der Pharmazie. 354(6). e2000486–e2000486. 11 indexed citations

15.

Ružić, Dušan, et al.. (2020). In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs. Frontiers in Chemistry. 7. 94 indexed citations

16.

Albert, Lea, Nemanja Djoković, Dušan Ružić, et al.. (2019). Modulating Protein–Protein Interactions with Visible‐Light‐Responsive Peptide Backbone Photoswitches. ChemBioChem. 20(11). 1417–1429. 36 indexed citations

17.

Avelar, Leandro A. Alves, Dušan Ružić, Nemanja Djoković, Thomas Kurz, & Katarina Nikolić. (2019). Structure-based design of selective histone deacetylase 6 zinc binding groups. Journal of Biomolecular Structure and Dynamics. 38(11). 3166–3177. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact